Search results

Jump to navigation Jump to search

Page title matches

  • ...<ref name="pmid16782492">{{cite journal |author=Sambrook P, Cooper C|title=Osteoporosis |journal=Lancet |volume=367 |issue=9527 |pages=2010–8 |year=2006 |pmid=16 As defined by the National Osteoporosis Foundation:
    49 KB (6,739 words) - 13:28, 10 February 2023
  • 12 bytes (1 word) - 10:26, 12 November 2007
  • 127 bytes (17 words) - 11:26, 5 February 2009
  • Auto-populated based on [[Special:WhatLinksHere/Osteoporosis]]. Needs checking by a human.
    1 KB (136 words) - 18:54, 6 February 2012

Page text matches

  • A fracture in the proximal end of the femur, often due to osteoporosis.
    108 bytes (16 words) - 09:00, 30 September 2009
  • A class of drugs that prevent the loss of bone mass, used to treat osteoporosis and similar diseases.
    138 bytes (21 words) - 05:13, 30 September 2009
  • ...[x-ray computed tomography]]. Bone density is an important predictor for [[osteoporosis]]."<ref>{{MeSH}}</ref> .../whqlibdoc.who.int/trs/WHO_TRS_921.pdf |title=Prevention and management of osteoporosis : report of a WHO scientific group| year=2003 |accessdate=2007-05-31 |forma
    2 KB (301 words) - 18:36, 30 May 2009
  • ...one and the risk of fractures; major applications are managing potential [[osteoporosis]] in postmenopausal women, and bone growth disorders in children
    252 bytes (35 words) - 18:13, 25 May 2010
  • ...y, such as vasomotor symptoms, dyspareunia, and progressive development of osteoporosis. This may also include the use of progestational agents in combination ther
    349 bytes (45 words) - 07:47, 5 July 2011
  • ...Menopausal Osteoporosis Prevention, Prevention of [[Glucocorticoid-induced osteoporosis]].<ref>{{citation ...t al.'' |title=Once-yearly zoledronic acid for treatment of postmenopausal osteoporosis |journal=N. Engl. J. Med. |volume=356 |issue=18 |pages=1809–22 |year=2007
    4 KB (599 words) - 09:12, 25 May 2010
  • {{r|Osteoporosis}}
    290 bytes (34 words) - 18:45, 27 December 2008
  • ...neration [[selective estrogen receptor modulator]] (SERM) used to prevent osteoporosis in postmenopausal women. It has estrogen agonist effects on bone and [[chol
    415 bytes (51 words) - 02:15, 7 October 2013
  • {{r|Osteoporosis}}
    470 bytes (49 words) - 00:25, 27 May 2010
  • {{r|Osteoporosis}}
    431 bytes (50 words) - 10:31, 6 November 2008
  • {{r|Osteoporosis}}
    874 bytes (98 words) - 01:01, 27 February 2009
  • {{r|Osteoporosis}}
    338 bytes (38 words) - 18:14, 25 May 2010
  • {{r|Osteoporosis}}
    487 bytes (62 words) - 11:27, 11 January 2010
  • {{r|Osteoporosis}}
    469 bytes (60 words) - 07:42, 8 January 2010
  • {{r|Osteoporosis}}
    464 bytes (59 words) - 15:36, 11 January 2010
  • {{r|Osteoporosis}}
    563 bytes (71 words) - 11:43, 11 January 2010
  • ...the risk of fractures. Major clinical uses include assessing the risk of osteoporosis and the need for preventive therapy in postmenopausal women, and in bone gr | title = Osteoporosis Tests
    5 KB (755 words) - 06:25, 12 September 2013
  • {{r|Osteoporosis}}
    796 bytes (99 words) - 10:52, 11 January 2010
  • {{r|Osteoporosis}}
    854 bytes (103 words) - 15:42, 11 January 2010
  • {{r|Osteoporosis}}
    994 bytes (123 words) - 16:54, 11 January 2010
View (previous 20 | ) (20 | 50 | 100 | 250 | 500)